Mallinckrodt (MNK) Shares Gap Up to $25.87

Mallinckrodt PLC (NYSE:MNK) shares gapped up prior to trading on Monday . The stock had previously closed at $25.46, but opened at $25.87. Mallinckrodt shares last traded at $25.61, with a volume of 94006 shares.

Several research analysts have weighed in on MNK shares. Stifel Nicolaus upped their target price on Mallinckrodt from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Monday, June 18th. SunTrust Banks upped their target price on Mallinckrodt to $21.00 and gave the stock a “hold” rating in a research report on Tuesday, June 19th. B. Riley upped their target price on Mallinckrodt from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, June 28th. Wells Fargo & Co upped their target price on Mallinckrodt from $15.00 to $21.00 and gave the stock a “market perform” rating in a research report on Monday, July 9th. Finally, Canaccord Genuity upped their target price on Mallinckrodt from $14.00 to $22.00 and gave the stock a “hold” rating in a research report on Thursday, July 19th. Four equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $31.30.

The company has a debt-to-equity ratio of 0.98, a current ratio of 2.27 and a quick ratio of 2.06. The firm has a market cap of $2.44 billion, a P/E ratio of 3.42, a PEG ratio of 0.49 and a beta of 1.61.

Mallinckrodt (NYSE:MNK) last issued its quarterly earnings data on Tuesday, August 7th. The company reported $1.78 EPS for the quarter, beating the Zacks’ consensus estimate of $1.48 by $0.30. The business had revenue of $631.70 million for the quarter, compared to analyst estimates of $621.15 million. Mallinckrodt had a return on equity of 10.39% and a net margin of 59.85%. Equities research analysts anticipate that Mallinckrodt PLC will post 6.7 earnings per share for the current year.

A number of large investors have recently made changes to their positions in MNK. Vident Investment Advisory LLC lifted its position in shares of Mallinckrodt by 1.7% in the 2nd quarter. Vident Investment Advisory LLC now owns 166,782 shares of the company’s stock worth $3,112,000 after acquiring an additional 2,807 shares during the period. United Services Automobile Association lifted its position in shares of Mallinckrodt by 18.4% in the 2nd quarter. United Services Automobile Association now owns 19,432 shares of the company’s stock worth $363,000 after acquiring an additional 3,026 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of Mallinckrodt by 22.7% in the 1st quarter. PNC Financial Services Group Inc. now owns 23,662 shares of the company’s stock worth $343,000 after acquiring an additional 4,381 shares during the period. Bronfman E.L. Rothschild L.P. lifted its position in shares of Mallinckrodt by 46.7% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 15,238 shares of the company’s stock worth $284,000 after acquiring an additional 4,853 shares during the period. Finally, Guggenheim Capital LLC lifted its position in shares of Mallinckrodt by 17.1% in the 1st quarter. Guggenheim Capital LLC now owns 40,863 shares of the company’s stock worth $592,000 after acquiring an additional 5,958 shares during the period.

Mallinckrodt Company Profile (NYSE:MNK)

Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products.

Featured Article: How Investors Use a Balance Sheet

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply